EDWARDS-LIFESCIENCES
21.6.2022 10:02:03 CEST | Business Wire | Press release
Edwards Lifesciences today published ‘Unifying Generations: Building the Pathway to Intergenerational Solidarity’ – a report, based on a survey of 12,850 Europeans across generations, that demonstrates the need to change perceptions of the value of people aged over-65 and their cohesion with younger generations.
“The European population is ageing. By 2040, 155 million people are expected to be over 651 . This demographic change is often referred to as a challenge, which gives a misleading and negative impression of the contributions of over-65s to the society, ” commented Jean-Luc Lemercier, Corporate Vice President, EMEA, Canada and Latin America, Edwards Lifesciences. “The survey results demonstrate that the senior population, and especially the pivotal 3rd generation, is an active, committed and engaged contributor to cohesion within families and the community. ”
To provide insights on the role of the senior population in society and the benefits of intergenerational interactions, Edwards Lifesciences joined forces with experts to conduct a survey examining the perceptions and experience of intergenerational solidarity of 12,850 citizens across 6 European countries (France, Germany, Ireland, Italy, Spain, and the UK). The results formed the basis of the newly available Unifying Generations report.
In contrast to existing perceptions, the survey results highlighted the significant social contributions of the 3rd generation. They contribute to their families and communities, through volunteering (19%) and providing care to others (24%).2 Seventy-one percent (71%) of over-65s also provide significant financial support to younger people.2 Younger generation respondents stated how important they felt the support the older generation provided was in their day-to-day lives, with 83% stating it was very important or somewhat important.2
“The Unifying Generations Survey gives an accurate picture of the current situation of intergenerational solidarity in several European countries. The results of this survey show a strong desire for more intergenerational interactions from both younger and older generations. The survey also presents the great value of listening, mentoring and coaching; contributing to community well-being through volunteering; sharing knowledge of new technology and digital skills; and many other ways of encouraging cooperation in a society for all ages. The survey data is a useful reference document that will encourage social organisations to promote intergenerational solidarity programs at local, national and international levels in European countries, ” commented Mr. Angel Yagüe Criado, Project Manager, The Spanish Confederation of Older People’s Association (CEOMA).
Results showed that the pandemic seems to have had a negative impact on intergenerational interaction, with 40% of respondents saying they spend less time with different generations since the pandemic.2 However, one of the most positive themes that emerged from the report was the willingness to improve intergenerational interactions. Respondents were 11 times more likely to think closer relations between different generations are a good thing (77%) vs. a bad thing (7%). 2 In fact, 92% of survey respondents confirmed they were open to having a friend from a different generation.
“The study suggests that extremely positive and varied intergenerational interactions are present in society and also valued by all age groups. It’s important that policies and strategies are developed that help maintain and strengthen these relations going forward, ” said Prof George W Leeson, Professorial Fellow, Oxford Institute of Population Ageing, University of Oxford.
A number of different benefits of improving intergenerational interactions were also highlighted. The most important benefits identified were companionship or friendship (20%) and mental and emotional wellbeing (19%). Additionally, 23% of younger respondents believe that mentoring or educational schemes provided by national or local government would help them to do more with older generations.2
The report recommends three actions that can be considered as a result of the survey findings. They are: a campaign to transform perceptions of the value of senior people and their interactions with younger generations, greater opportunities for mentoring and knowledge sharing from older to younger generations; and schemes that help senior people interact more digitally.
“Recognising and celebrating the knowledge, skills, and experiences of senior people is at the heart of the report and of promoting intergenerational solidarity ,” added Jean-Luc Lemercier. “As we build back after the pandemic, we should change perceptions of the value our senior populations – particularly the pivotal 3rd generation – provide to society and the importance of protecting their health and well-being .”
To learn more and download the full report please visit https://www.edwards.com/ch-en/aboutus/unifying-generations/ .
About Edwards Lifesciences
Edwards Lifesciences, is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape. For more information, visit Edwards.com and follow us on LinkedIn and Twitter .
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.
About Unifying Generations
Unifying Generations is an initiative that springs from the company’s commitment to the patients it serves and illustrates the aspiration to create a community unified in its mission to improve the quality of life around the world.
###
1 Eurostat (2017) People in the EU – population projections, http://ec.europa.eu/eurostat/statistics-explained/index.php?-title=People_in_the_EU_-_population_projections
2 Censuswide. Unifying Generations. A survey of over 12,850 people in Europe. Survey carried out 04/04/2022 – 14/04/2022. Data on file. Survey funded by Edwards Lifesciences.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220621005242/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kiabi Selects Navan to Centralise Global Travel Program11.5.2026 09:00:00 CEST | Press release
Fashion retailer targets high employee adoption and efficiency with AI-powered travel platform Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced it has been selected by Kiabi, the French multinational fashion retailer, to consolidate its global travel with one unified platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260511547434/en/ Fashion retailer targets high employee adoption and efficiency with AI-powered travel platform To support its workforce of nearly 10,000 “Kiabers,” the retailer required a solution capable of providing an easy-to-use travel platform. Navan was selected due to its intuitive AI-powered interface and ability to integrate with Kiabi’s travel policies directly in-app. “Managing travel was becoming an administrative burden that slowed our teams down,” said Denise Maurice, Indirect Procurement Director at Kiabi. “We wanted to give our ‘Kiabers’ the
Owl Labs partners with Westcoast to expand access to seamless hybrid meeting experiences in the UK and Ireland11.5.2026 09:00:00 CEST | Press release
Partnership aims to reduce the ‘meeting tax’ by expanding access to Owl Labs products through Westcoast’s extensive distribution network Owl Labs, a global leader in AI-powered, 360-degree video conferencing solutions, today announced a new UK and Ireland distribution partnership with Westcoast Limited, one of the country’s largest and most trusted IT distributors. The agreement will see Westcoast distribute the full range of Owl Labs’ award-winning Meeting Owl and Owl Bar products across the UK and Ireland, providing greater choice, availability, and dedicated support for resellers and end customers navigating the demands of hybrid work. The partnership aims to address the technical setup challenges that plague meetings across the UK. Owl Labs’ recent State of Hybrid Work report found that nearly 8 in 10 workers (79%) lose time in meetings due to technical difficulties such as connecting to a meeting or setting up a camera. By making Owl Labs’ solutions simpler to source, deploy and s
Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G pTau 217 Plasma Assay11.5.2026 09:00:00 CEST | Press release
H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Fujirebio Europe N.V. has obtained a CE certificate of the Lumipulse G pTau 217 Plasma assay under the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). This CLEIA (chemiluminescent enzyme immunoassay) test allows for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human plasma (K2EDTA). “With Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma now CE‑marked on our LUMIPULSE G platform, we are advancing a new era of neurology diagnostics—one where blood‑based biomarkers enable earlier, broader, and more accessible insights into Alzheimer’s disease and neurodegeneration.” said Christiaan De Wilde, CEO at Fujirebio Europe N.V. “By delivering fully automated and scalable solutions, we are helping clinicians move decisively toward more timely and informed decision‑making. This milestone underscores our long‑term vision to reimagine the diagnostic
Mevion Introduces the First Proton Therapy System Designed for a LINAC Vault at ESTRO 202611.5.2026 08:00:00 CEST | Press release
The MEVION S250-FIT™ creates a new pathway for European cancer centers to integrate proton therapy into existing radiotherapy programs Proton therapy is entering the LINAC vault. At ESTRO 2026, Mevion Medical Systems will introduce the MEVION S250-FIT Proton Therapy System to the European radiation oncology community, the first proton therapy system designed for installation in a standard radiation therapy vault. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507172087/en/ The MEVION S250-FIT™ Proton Therapy System Now both U.S. FDA-cleared and CE-marked under Regulation (EU) 2017/745, the S250-FIT creates a new pathway for cancer centers to bring proton therapy into existing LINAC-based treatment environments, aligning advanced proton capability with the infrastructure, workflows, and capital planning of modern radiation oncology. Stanford Medicine: First S250-FIT Installation On April 7, 2026, Stanford Medicine unveiled
Vedanta FY26 Profit Soars by 22% to $2.8 bn; Enters Demerger Phase11.5.2026 02:30:00 CEST | Press release
India-based Vedanta Limited (BSE: 500295 & NSE: VEDL), a global leader in metals, oil & gas, critical minerals, power and technology, announced its results for the fourth quarter and full year ended 31 March 2026. It has delivered its best-ever financial performance, driven by structurally strong businesses and disciplined execution. For the full year, Vedanta’s Profit stood at an all-time high of $2.8 bn, reflecting a 22% YoY increase and a profit of $1 bn in Q4 FY26, up nearly 90% YoY. Vedanta reported its highest-ever annual revenue of about $20 bn, up 15% YoY, with Q4 revenue at $5.6 bn, an increase of nearly 30% YoY. The Company maintained strong cost leadership, contributing to record EBITDA of $6.3 bn for FY26, up by about 30% YoY, with margins expanding to around 40%. Q4 EBITDA stood at $2.0 bn, up by nearly 60% YoY, with a margin of approximately 44%. The balance sheet strengthened further, with Net Debt/EBITDA improving to 0.95x, supported by strong cash generation. Underscor
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
